春立医疗收盘上涨2.83%，滚动市盈率46.86倍，总市值59.91亿元

Group 1 - The core viewpoint of the article highlights that Chunli Medical's stock closed at 15.62 yuan, with a 2.83% increase, and a rolling PE ratio of 46.86 times, with a total market value of 5.991 billion yuan [1] - The average PE ratio for the medical device industry is 50.06 times, with a median of 36.80 times, placing Chunli Medical at the 87th position in the industry ranking [1] - As of the first quarter of 2025, 13 institutions hold shares in Chunli Medical, including 8 funds, 4 others, and 1 brokerage, with a total holding of 31.6307 million shares valued at 429 million yuan [1] Group 2 - Chunli Medical specializes in the research, production, and sales of implantable orthopedic medical devices, with main products including spinal, trauma, joint, sports medicine implants, bone repair materials, surgical instruments, PRP preparation kits, and negative pressure drainage kits [1] - The company was recognized as a champion enterprise in the artificial joint prosthesis manufacturing industry by the Ministry of Industry and Information Technology in 2024 [1] - The latest performance report for the first quarter of 2025 shows that the company achieved an operating income of 230 million yuan, a year-on-year increase of 3.60%, and a net profit of 58.0711 million yuan, a year-on-year increase of 5.20%, with a gross sales margin of 66.69% [1]